{"id":40960,"date":"2026-05-22T17:45:00","date_gmt":"2026-05-22T15:45:00","guid":{"rendered":"https:\/\/www.transgene.com\/?p=40960"},"modified":"2026-05-26T09:09:51","modified_gmt":"2026-05-26T07:09:51","slug":"dorothea-ledergerber","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/dorothea-ledergerber\/","title":{"rendered":"Dorothea Ledergerber"},"content":{"rendered":"\n<p><img decoding=\"async\" class=\"imgMembers wp-image-28056 size-medium aligncenter\" src=\"https:\/\/www.transgene.com\/wp-content\/uploads\/D_Lederberger.jpg\" alt=\"&quot;\" \/><\/p>\n<p><br \/>Dorothea Ledergerber occupe actuellement les fonctions de Multi-Site Head Drug Product Operations au sein du groupe Siegfried, et si\u00e8ge par ailleurs au conseil d\u2019administration du CDMO DINAMIQS. Pharmacienne de formation, titulaire d\u2019un doctorat en sciences pharmaceutiques, elle dispose de plus de 25 ans d\u2019exp\u00e9rience dans l\u2019industrie pharmaceutique et biotechnologique. Elle a exerc\u00e9 des responsabilit\u00e9s de direction au sein de Novartis, o\u00f9 elle a notamment dirig\u00e9 des op\u00e9rations industrielles en Europe et contribu\u00e9 \u00e0 la mise en place de la premi\u00e8re unit\u00e9 commerciale europ\u00e9enne de production de th\u00e9rapies cellulaires et g\u00e9niques du groupe. Elle a \u00e9galement occup\u00e9 les fonctions de Chief Technical Officer chez Tigen Pharma, sp\u00e9cialis\u00e9e dans les th\u00e9rapies cellulaires autologues. Mme Ledergerber poss\u00e8de une expertise reconnue couvrant l\u2019ensemble de la cha\u00eene de valeur pharmaceutique, de la recherche et du d\u00e9veloppement \u00e0 la production.<\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dorothea Ledergerber occupe actuellement les fonctions de Multi-Site Head Drug Product Operations au sein du groupe Siegfried, et si\u00e8ge par ailleurs au conseil d\u2019administration du CDMO DINAMIQS. Pharmacienne de formation, titulaire d\u2019un doctorat en sciences pharmaceutiques, elle dispose de plus de 25 ans d\u2019exp\u00e9rience dans l\u2019industrie pharmaceutique et biotechnologique. Elle a exerc\u00e9 des responsabilit\u00e9s de&hellip; <a class=\"more-link\" href=\"https:\/\/www.transgene.com\/fr\/dorothea-ledergerber\/\">Poursuivre la lecture <span class=\"screen-reader-text\">Dorothea Ledergerber<\/span><\/a><\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[111],"tags":[],"class_list":["post-40960","post","type-post","status-publish","format-standard","hentry","category-outils-profils","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"cat18","author_link":"https:\/\/www.transgene.com\/fr\/author\/cat18\/"},"uagb_comment_info":0,"uagb_excerpt":"Dorothea Ledergerber occupe actuellement les fonctions de Multi-Site Head Drug Product Operations au sein du groupe Siegfried, et si\u00e8ge par ailleurs au conseil d\u2019administration du CDMO DINAMIQS. Pharmacienne de formation, titulaire d\u2019un doctorat en sciences pharmaceutiques, elle dispose de plus de 25 ans d\u2019exp\u00e9rience dans l\u2019industrie pharmaceutique et biotechnologique. Elle a exerc\u00e9 des responsabilit\u00e9s de&hellip;\u2026","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/40960","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=40960"}],"version-history":[{"count":3,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/40960\/revisions"}],"predecessor-version":[{"id":41051,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/40960\/revisions\/41051"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=40960"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=40960"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=40960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}